Word

SGX PHARMACEUTICALS

Status

Dead

Status Code

710

Status Date

Friday, June 5, 2015

Serial Number

78702351

Registration Number

3529111

Registration Date

Tuesday, November 4, 2008

Mark Type

3000

Filing Date

Monday, August 29, 2005

Published for Opposition

Tuesday, January 2, 2007

Cancellation Date

Friday, June 5, 2015

Trademark Owner History

SGX PHARMACEUTICALS, INC. - Original Registrant
Structural GenomiX, Inc. - Original Applicant

Classifications

1 Chemicals used for drug discovery, drug design, drug development, structural biology, scientific analysis, kinase inhibition, or biotechnology; chemical compounds and chemical formulations used for drug discovery, drug design, drug development, structural biology, scientific analysis, kinase inhibition, or biotechnology; proteins and protein crystals used for crystallization, drug discovery, drug design, drug development, structural biology, structure determination, scientific analysis or research, or biotechnology; chemicals and chemical preparations used for design, manufacture or development of pharmaceuticals, or pharmaceutical preparations

5 Pharmaceuticals and pharmaceutical preparations used for kinase inhibition or for treating cancer, viral infections, tumors, hematological or oncological disorders, inflammatory disorders, infectious diseases, immune system disorders, allergic disorders, cardiovascular disorders, pulmonary disorders, gastrointestinal disorders, hepatic and biliary disorders, nutritional and metabolic disorders, endocrine disorders, gynecological disorders, obstetric conditions, musculoskeletal and connective tissue disorders, neurological disorders, psychiatric disorders, genitourinary disorders, pediatric conditions, otolaryngological disorders, ophthalmologic disorders, dermatological disorders, dental and oral disorders, disorders due to physical agents, poisoning, venomous bites or stings, or human disease; chemicals and chemical formulations for medical use or for kinase inhibition or for treating human disease, hematological or oncological disorders, or inflammatory disorders

9 Computer software for use in drug discovery, pharmaceutical research, or biotechnology research; computer software for chemical analysis and identification, design, or modification of chemical entities; computer software for protein structure or protein crystal analysis; computer software for coordinated chemical and protein structure analysis

42 Pharmaceutical research, drug discovery, and drug development services; chemical structure analysis or design; identification, design, or modification of chemical entities; protein structure, protein crystal, or protein co-crystal analysis; biotechnology research; bioinformatics research; scientific analysis

Color is not claimed as a feature of the mark.
"PHARMACEUTICALS"

Trademark Events

Jun 5, 2015

Cancelled Sec. 8 (6-Yr)

Nov 4, 2008

Registered-Principal Register

Sep 30, 2008

Law Office Registration Review Completed

Sep 30, 2008

Allowed Principal Register - Sou Accepted

Sep 15, 2008

Amendment From Applicant Entered

Sep 15, 2008

Correspondence Received In Law Office

Sep 15, 2008

Assigned To Lie

Sep 11, 2008

Paper Received

Mar 10, 2008

Notification Of Final Refusal Emailed

Mar 10, 2008

Final Refusal E-Mailed

Mar 10, 2008

Su - Final Refusal - Written

Feb 25, 2008

Attorney Revoked And/Or Appointed

Feb 25, 2008

Teas Revoke/Appoint Attorney Received

Feb 17, 2008

Teas/Email Correspondence Entered

Feb 17, 2008

Correspondence Received In Law Office

Feb 17, 2008

Assigned To Lie

Jan 16, 2008

Teas Response To Office Action Received

Oct 26, 2007

Notification Of Non-Final Action E-Mailed

Oct 26, 2007

Non-Final Action E-Mailed

Oct 26, 2007

Su - Non-Final Action - Written

Oct 4, 2007

Statement Of Use Processing Complete

Sep 24, 2007

Use Amendment Filed

Oct 4, 2007

Extension 1 Granted

Sep 24, 2007

Extension 1 Filed

Sep 24, 2007

Teas Extension Received

Sep 24, 2007

Teas Statement Of Use Received

Mar 27, 2007

Noa Mailed - Sou Required From Applicant

Jan 2, 2007

Published For Opposition

Dec 13, 2006

Notice Of Publication

Nov 13, 2006

Law Office Publication Review Completed

Nov 9, 2006

Assigned To Lie

Nov 3, 2006

Approved For Pub - Principal Register

Nov 3, 2006

Examiners Amendment Mailed

Nov 2, 2006

Examiner's Amendment Entered

Nov 2, 2006

Examiners Amendment -Written

Oct 4, 2006

Assigned To Examiner

Sep 25, 2006

Teas/Email Correspondence Entered

Sep 21, 2006

Correspondence Received In Law Office

Sep 21, 2006

Teas Response To Office Action Received

Mar 21, 2006

Non-Final Action Mailed

Mar 20, 2006

Non-Final Action Written

Mar 15, 2006

Assigned To Examiner

Sep 6, 2005

New Application Entered In Tram